Neulander et al., 2010 - Google Patents
Re: Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. Y. Yang, Z.-t. Wei, X. Zhang, B.-F. Hong and G. Guo. J Urol 2009; 182: 66-69Neulander et al., 2010
- Document ID
- 6687201544471104360
- Author
- Neulander E
- Katz T
- Klein J
- Kaneti J
- Publication year
- Publication venue
- The Journal of urology
External Links
- 238000009800 partial cystectomy 0 title description 5
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2012057967A3 (en) | Methods and apparatus for controlling photoresist line width roughness | |
| ZA201605200B (en) | An incising implant for the prostatic urethra | |
| EP2271276A4 (en) | Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy | |
| EP2555699A4 (en) | Power generating and control apparatus for the treatment of tissue | |
| PL2285490T3 (en) | Bimetallic catalytic complexes for the copolymerisation of carbon dioxide and an epoxide | |
| PL2405842T3 (en) | High frequency electrosurgical generator with an additional transformer | |
| WO2008137867A3 (en) | Compositions comprising mir34 therapeutic agents for treating cancer | |
| WO2011119957A3 (en) | Systems and methods for prostate treatment | |
| WO2012170776A3 (en) | Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy | |
| PL2559439T3 (en) | Pharmaceutical preparation for treating benign prostatic hyperplasia | |
| WO2009156117A3 (en) | Apparatus for magnetic field therapy | |
| ZA201109513B (en) | Composition for the treatment of benign prostate hyperplasia | |
| EP3068414A4 (en) | Compositions and methods useful in treatment of lower urinary tract sysptoms, benign prostatic hyperplasia, erectile dysfunction | |
| WO2011097522A3 (en) | Combination methods for treatment of disease | |
| Neulander et al. | Re: Transurethral partial cystectomy with continuous wave laser for bladder carcinoma. Y. Yang, Z.-t. Wei, X. Zhang, B.-F. Hong and G. Guo. J Urol 2009; 182: 66-69 | |
| Lam | From British Colonization to Japanese Invasion: The 100 Years Architects in Hong Kong 1841-1941 | |
| Gudjónsson et al. | Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009; 56; 43-5 | |
| Smith Jr | Words of wisdom. Re: androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology | |
| Kaplan | Re: phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia | |
| Goyal et al. | Re: Does low intensity extracorporeal shock wave therapy have a physiological effect on erectile function? Short-term results of a randomized, double-blind, sham controlled study: Y. Vardi, B. Appel, A. Kilchevsky and I. Gruenwald. J Urol 2012; 187: 1769-1775 | |
| Kaplan | Re: Greenlight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up | |
| UA62537U (en) | Method for endoscopic treatment of benign prostate hyperplasia when ureter ostiacould not be identified | |
| Kaplan | Re: Comparison of Murraya koenigii-and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged> 50 years: a double-blind, double-dummy, randomized controlled trial | |
| AU2010101329A4 (en) | Time bezier algorithm | |
| PH12012502483A1 (en) | An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |